10-60519366-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.96+95820G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0997 in 152,092 control chromosomes in the GnomAD database, including 1,215 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1215 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.624

Publications

39 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.297 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.63+53099G>A intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001204403.2 linkc.96+95820G>A intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.96+95820G>A intron_variant Intron 2 of 43 1 ENSP00000362933.2 Q12955-5
ANK3ENST00000503366.6 linkc.63+53099G>A intron_variant Intron 1 of 43 2 ENSP00000425236.1 Q12955-4
ANK3ENST00000510382.1 linkn.102-10741G>A intron_variant Intron 2 of 2 2
ANK3ENST00000622427.4 linkn.63+53099G>A intron_variant Intron 1 of 32 2 ENSP00000483244.1 A0A087X0B4

Frequencies

GnomAD3 genomes
AF:
0.0997
AC:
15158
AN:
151974
Hom.:
1210
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0663
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.205
Gnomad ASJ
AF:
0.0776
Gnomad EAS
AF:
0.311
Gnomad SAS
AF:
0.162
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0653
Gnomad OTH
AF:
0.0873
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0997
AC:
15166
AN:
152092
Hom.:
1215
Cov.:
32
AF XY:
0.109
AC XY:
8125
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0662
AC:
2750
AN:
41522
American (AMR)
AF:
0.206
AC:
3143
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.0776
AC:
269
AN:
3466
East Asian (EAS)
AF:
0.310
AC:
1595
AN:
5148
South Asian (SAS)
AF:
0.160
AC:
768
AN:
4812
European-Finnish (FIN)
AF:
0.189
AC:
1997
AN:
10564
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0653
AC:
4442
AN:
68002
Other (OTH)
AF:
0.0883
AC:
186
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
635
1270
1905
2540
3175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0807
Hom.:
3826
Bravo
AF:
0.102
Asia WGS
AF:
0.238
AC:
826
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.8
DANN
Benign
0.50
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10994397; hg19: chr10-62279124; API